| Literature DB >> 15109822 |
Zhijun Wang1, Zhenghong Yuan, Ulrich R Hengge.
Abstract
With the increasing utilization of plasmid DNA as a biopharmaceutical drug, there is a rapidly growing need for high quality plasmid DNA for drug applications. Although there are several different kinds of replication origins, ColE1-like replication origin is the most extensively used origin in biotechnology. This review addresses problems in upstream and downstream processing of plasmid DNA with ColE1-like origin as drug applications. In upstream processing of plasmid DNA, regulation of replication of ColE1-like origin was discussed. In downstream processing of plasmid DNA, we analyzed simple, robust, and scalable methods, which can be used in the efficient production of pharmaceutical-grade plasmid DNA. Copyright 2004 Elsevier, Inc.Mesh:
Substances:
Year: 2004 PMID: 15109822 DOI: 10.1016/j.plasmid.2003.12.002
Source DB: PubMed Journal: Plasmid ISSN: 0147-619X Impact factor: 3.466